CompaniesActivated Cell Therapy

Activated Cell Therapy

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

1

As Collaborator

4

Total Enrollment

50

By Phase

PHASE1/PHASE2: 4PHASE1: 1

By Status

COMPLETED: 3WITHDRAWN: 1SUSPENDED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT01621724
NCT02611609
NCT02949414
NCT04435249
Hover over trial bars to see details

Recent Trials

NCT04435249Collaborator
ENgineered Tissue Repair of BronchopleUral FiSTula
PHASE1/PHASE2Withdrawn
Started: Oct 31, 2025 · Completed: Nov 30, 2028
NCT02949414Lead Sponsor
A Study to Assess the Safety, Tolerability and Potential Efficacy of a Tracheal Replacement Consisting of a Tissue-engineered Tracheal Scaffold With Seeded Mesenchymal Cells
PHASE1Suspended
4 participants
Started: Sep 30, 2016 · Completed: Sep 30, 2024
NCT02611609Collaborator
A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome
PHASE1/PHASE2Completed
36 participants
Started: Jan 31, 2016 · Completed: Jul 31, 2019
NCT02550535Collaborator
A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients
PHASE1/PHASE2Completed
3 participants
Started: Sep 30, 2015 · Completed: May 31, 2018
NCT01621724Collaborator
WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study
PHASE1/PHASE2Completed
7 participants
Started: Apr 30, 2012 · Completed: May 31, 2018